Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 181-190 of 9381

Page
per page
  1. Withaferin A
    B7199 Withaferin A
     2 Citation
    Summary: Prevents NF-κB activation by inhibiting activation of IKKβ
      Soluble in DMSO
  2. Sulprostone
    B7255 Sulprostone
    Summary: EP3 and EP1 receptor agonist
  3. Sodium acetate
    B7296 Sodium acetate
    Summary: Commonly used laboratory reagent
      ≥8.2 mg/mL
  4. Latrunculin A
    B7555 Latrunculin A
    Target: Actin
    Summary: Reversible inhibitor of actin assembly
      soluble in DMSO
  5. Puromycin dihydrochloride
    B7587 Puromycin dihydrochloride
    Summary: Puromycin dihydrochloride
      ≥27.2 mg/mL
  6. Quinidine
    B7590 Quinidine
    Target: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)
    Summary: reduces both Na+ and K+ channel currents
  7. MTT
    B7777 MTT
     2 Citation
    Summary: reagent used in the measurement of in vitro cell proliferation
      ≥41.4 mg/mL
  8. Neurotensin
    B5226 Neurotensin
     2 Citation
    Summary: NTR1 activator
      insoluble in EtOH; ≥15.33 mg/mL
  9. Galnon
    B5256 Galnon
    Summary: Novel non-peptide galanin GAL1 and GAL2 receptor agonist
      ≥24.7 mg/mL
  10. Decanoyl-RVKR-CMK
    B5437 Decanoyl-RVKR-CMK
    Target: Subtilisin/Kex2p-like proprotein convertase
    Summary: Subtilisin/Kex2p-like proprotein convertase inhibitor

Items 181-190 of 9381

Page
per page